Immunic (IMUX) Non-Current Assets (2013 - 2026)

Immunic (IMUX) has 14 years of Non-Current Assets data on file, last reported at $983000.0 in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 36.17% year-over-year to $983000.0; the trailing twelve-month figure through Mar 2026 stood at $5.2 million (down 14.81% YoY), and the FY2025 full-year result was $1.2 million, down 22.98% from the prior year.
• Non-Current Assets slipped to $983000.0 in Q1 2026, from $1.2 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $34.4 million in Q3 2022 to a low of $983000.0 in Q1 2026.
• A 5-year average of $7.4 million and a median of $1.6 million in 2025 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets tumbled 94.94% in 2023 and grew 4.89% in 2025, its largest moves.
• Tracing IMUX's Non-Current Assets over 5 years: stood at $1.9 million in 2022, then dropped by 6.56% to $1.8 million in 2023, then retreated by 12.97% to $1.5 million in 2024, then dropped by 22.98% to $1.2 million in 2025, then dropped by 16.91% to $983000.0 in 2026.
• Business Quant data shows IMUX's Non-Current Assets at $983000.0 in Q1 2026, $1.2 million in Q4 2025, and $1.4 million in Q3 2025.